Catamaran Holds Annual and Special Meeting of Shareholders SCHAUMBURG, Ill.,

May 14, 2014 - Catamaran Corporation (the
"Company"
or "Catamaran")
(NASDAQ: CTRX) (TSX:CCT) a leading provider of technology and
pharmacy benefit management
services is pleased to announce that at its annual and special meeting of shareholders held on May 13,
2014, each of the nine nominees listed in its management information circular dated April 1, 2014 was elected as a director. The detailed results of the voting are as follows:

Nominee

Peter J. Bensen

Votes For

114,330,137

% For

99.9%

Votes Withheld

157,457

% Withheld

0.1%

Steven D. Cosler

111,571,820

97.5%

2,915,774

2.5%

William J. Davis

112,775,746

98.5%

1,711,848

1.5%

Steven B. Epstein

111,560,493

97.4%

2,927,101

2.6%

Betsy Holden

111,502,318

97.4%

2,917,736

2.6%

Karen Katen

113,558,968

99.2%

861,086

0.8%

Harry M. Kraemer

111,744,049

97.7%

2,676,005

2.3%

Anthony R. Masso

114,261,712

99.9%

158,342

0.1%

Mark A. Thierer

112,993,971

98.7%

1,493,623

1.3%

In addition to the election of the Company's nine directors, the Company's shareholders approved the
Amended and Restated Bonus Plan, approved the material terms of the performance measures under the
Catamaran Corporation Third Amended and Restated
Long-Term
Incentive Plan, ratified the
appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2014, and approved, on an advisory basis, the compensation of the Company's named executive officers.

About Catamaran

Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the
communities they serve take control of prescription drug
costs. Managing more
than 350
million
prescriptions each year on behalf of over 32 million members, our flexible, holistic solutions improve
patient care and empower individuals to take charge of
their health.
Processing
one in every five
prescription claims in
the U.S.,
Catamaran's
skill and scale deliver compelling financial results and
sustainable improvement in the overall health of members. Catamaran is headquartered in Schaumburg, Ill., with multiple locations in the U.S. and Canada. For more information, please visit CatamaranRx.com, and for industry news and information, follow Catamaran on Twitter, @CatamaranCorp.

For more information, please contact:

Tony Perkins
Investor Relations

Catamaran (312) 261-7805 tony.perkins@catamaranRx.com
distributed by